Ontology highlight
ABSTRACT:
SUBMITTER: Szulkin R
PROVIDER: S-EPMC5674990 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature
Szulkin Robert R Karlsson Robert R Whitington Thomas T Aly Markus M Gronberg Henrik H Eeles Rosalind A RA Easton Douglas F DF Kote-Jarai Zsofia Z Al Olama Ali Amin AA Benlloch Sara S Muir Kenneth K Giles Graham G GG Southey Melissa C MC FitzGerald Liesel M LM Henderson Brian E BE Schumacher Fredrick R FR Haiman Christopher A CA Sipeky Csilla C Tammela Teuvo L J TL Nordestgaard Børge G BG Key Timothy J TJ Travis Ruth C RC Neal David E DE Donovan Jenny L JL Hamdy Freddie C FC Pharoah Paul D P PD Pashayan Nora N Khaw Kay-Tee KT Stanford Janet L JL Thibodeau Stephen N SN McDonnell Shannon K SK Schaid Daniel J DJ Maier Christiane C Vogel Walther W Luedeke Manuel M Herkommer Kathleen K Kibel Adam S AS Cybulski Cezary C Lubiński Jan J Kluźniak Wojciech W Cannon-Albright Lisa L Brenner Hermann H Herrmann Volker V Holleczek Bernd B Park Jong Y JY Sellers Thomas A TA Lim Hui-Yi HY Slavov Chavdar C Kaneva Radka P RP Mitev Vanio I VI Spurdle Amanda A Teixeira Manuel R MR Paulo Paula P Maia Sofia S Pandha Hardev H Michael Agnieszka A Kierzek Andrzej A Batra Jyotsna J Batra Jyotsna J Clements Judith A JA Albanes Demetrius D Andriole Gerald L GL Berndt Sonja I SI Chanock Stephen S Gapstur Susan M SM Giovannucci Edward L EL Hunter David J DJ Kraft Peter P Le Marchand Loic L Ma Jing J Mondul Alison M AM Penney Kathryn L KL Stampfer Meir J MJ Stevens Victoria L VL Weinstein Stephanie J SJ Trichopoulou Antonia A Bueno-de-Mesquita Bas H BH Tjønneland Anne A Cox David G DG Maehle Lovise L Schleutker Johanna J Lindström Sara S Wiklund Fredrik F
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20150825 11
<h4>Background</h4>Unnecessary intervention and overtreatment of indolent disease are common challenges in clinical management of prostate cancer. Improved tools to distinguish lethal from indolent disease are critical.<h4>Methods</h4>We performed a genome-wide survival analysis of cause-specific death in 24,023 prostate cancer patients (3,513 disease-specific deaths) from the PRACTICAL and BPC3 consortia. Top findings were assessed for replication in a Norwegian cohort (CONOR).<h4>Results</h4>W ...[more]